Expert Links Prescription Opioid Supply to Washington’s Addiction Crisis August 14, 2026 On Wednesday, Columbia University epidemiology professor Katherine Keyes testified that the increased availability of prescription opioids beginning in the early 2000s helped set the stage for later waves of heroin and synthetic opioid use, including fentanyl. Keyes described the crisis as a three-wave epidemic. According to her testimony, the widespread distribution of prescription opioids was […] Read More
Expert Testimony Raises Questions About Albertsons’ Opioid Records July 21, 2026 Levin Papantonio Senior Partner Peter Mougey questioned a key expert witness this week as Washington State’s opioid trial against Albertsons continued in King County Superior Court. During Monday’s proceedings, Craig McCann of SLGC Economic Consulting testified about his analysis of opioid distribution and dispensing records from Albertsons pharmacies in Washington. McCann said his analysis compared […] Read More
Reuters Highlights Washington Albertsons Opioid Trial Following National Settlement July 14, 2026 Reuters recently highlighted the start of Washington State’s trial against Albertsons, one of the remaining opioid cases proceeding after the company’s previously announced $774 million nationwide settlement. The state alleges Albertsons’ pharmacy practices contributed to the opioid epidemic by failing to adequately identify and address warning signs associated with opioid prescriptions. Albertsons denies the allegations. […] Read More